How effective are breast cancer screening programmes by mammography? Review of the current evidence

European Journal of Cancer

Volumn 45, Issue 11, 2009, Pages 1916-1923

  Schopper, Doris ^a   de Wolf, Chris ^b  

^a Health Policy and Programme Development   (Switzerland)

^b Agence pour le développement et évaluation des politique de santé Adsan   (Switzerland)

Author keywords

Breast cancer; Mammography; Mortality reduction; Screening

Indexed keywords

ARTICLE; AUSTRALIA; BREAST CANCER; CANADA; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; DENMARK; FINLAND; HEALTH PROGRAM; HUMAN; ICELAND; ITALY; MAMMOGRAPHY; MEDLINE; NETHERLANDS; OVERALL SURVIVAL; PRIORITY JOURNAL; SPAIN; SWEDEN; UNITED KINGDOM;

AGED; AUSTRALIA; BREAST NEOPLASMS; CANADA; EARLY DETECTION OF CANCER; EUROPE; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED;

EID: 67649344098     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.03.022     Document Type: Article

References (49)

1. Gotzsche P.C., and Olsen O. Is screening for breast cancer with mammography justifiable?. Lancet 355 (2000) 129-134
2. Olsen O., and Gotzsche P.C. Cochrane review on screening for breast cancer with mammography. Lancet 358 (2001) 1340-1342
3. Olsen O, Gotzsche PC. Systematic review of screening for breast cancer with mammography. ; 2001.
4. Gotzsche P.C., and Nielsen M. Screening for breast cancer with mammography (Review) (2006), John Wiley and Sons, Berlin [Report No.: Art. No.: CD001877]
5. Humphrey L.L., Helfand M., Chan B.K.S., and Woolf S.H. Breast cancer screening: a summary of the evidence for the US preventive services task force. Ann Intern Med 137 5 (2002) 347-360
6. International Agency for Cancer research. Efficacy of screening. In: Vainio H., and Bianchini F. (Eds). Breast cancer screening (2002), IARC Press, Lyon, France 87-118
7. van Veen WA, Health Council of the Netherlands. The benefit of population screening for breast cancer with mammography. The Hague: Health Council of the Netherlands; 7 March 2002 [Report No.: Publication No.: 2002/03E].
8. US Preventive Task Force. Screening for breast cancer: recommendations and rationale. Ann Intern Med 137 5 (2002) 344-346
9. Boyle P. Mammographic breast cancer screening: after the dust has settled. The Breast 12 (2003) 351-356
10. Miettinen O.S., Henschke C.I., Pasmantier M.W., Smith J.P., Libby D.M., and Yankelevitz D.F. Mammographic screening: no reliable supporting evidence?. Lancet 359 (2002) 404-405
11. Duffy S.W., Tabar L., and Smith R.A. The mammographic screening trials: commentary on the recent work by Olsen and Gotzsche. CA Cancer J Clin 52 (2002) 68-71
12. Green B.B., and Taplin S.H. Breast cancer screening controversies. J Am Board Fam Pract 16 3 (2003) 233-241
13. Bouchardy C., Raymond L., and de Wolf C. L'efficacité du dépistage mammographique est-elle vraiment contestable? Une revue critique de l'article de Gøtzsche et Olsen. Schweizerische Aerztezeitung 82 12 (2001) 588-594
14. de Koning H.J. Mammographic screening: evidence from randomised controlled trials. Ann Oncol 14 8 (2003) 1185-1189
15. Freedman D.A., Petitti D.B., and Robins J.M. On the efficacy of screening for breast cancer. Int J Epidemiol 33 (2004) 43-55
16. Agence Nationale d'Accréditation et d'Evaluation en Santé (AENES). Dépistage du cancer du sein par mammographie: évaluation de la méta-analyse de Gotzsche et Olsen. Paris: Agence Nationale d'Accréditation et d'Evaluation en Santé; 2002.
17. Nyström L., Andersson I., Bjurstam N., Nordensköld B., and Rutqvist L.E. Long-term effects of mammography screening: updated review of the Swedish randomised trials. Lancet 359 (2002) 909-919
18. International Agency for Cancer research. Effectiveness of screening. In: Vainio H., and Bianchini F. (Eds). Breast cancer screening (2002), IARC Press, Lyon, France 119-156
19. Gabe R., and Duffy S.W. Evaluation of service screening mammography in practice: the impact on breast cancer mortality. Ann Oncol 16 Suppl. 2 (2005) ii153-ii162
20. Advisory Committee on Breast Cancer Screening. Screening for breast cancer in England: past and future. NHS Cancer Screening Programmes; 2006 [Report No.: 61].
21. Deck WKR. Screening mammography: a reassessment. Montréal, Canada: Agence d'évaluation des technologies et des modes d'interventions en santé (AETMIS); 2006 [Report No.: AETMIS 05-03].
22. Australian Institute of Health and Welfare and National Breast Cancer Centre. Breast cancer in Australia: an overview, 2006. Canberra, AIHW Cat. No. CAN 29: Australian Institute of Health and Welfare; 2006 [Report No.: 34].
23. Roder D., Houssami N., Farshid G., et al. Population screening and intensity of screening are associated with reduced breast cancer mortality: evidence of efficacy of mammography screening in Australia. Breast Cancer Res Treat 108 (2008) 409-416
24. Cuzick J., Edwards R., and Segnan N. Adjusting for non-compliance and contamination in randomized clinical trials. Stat Med 16 (1997) 1017-1029
25. Duffy S.W., Olsen A.H., Gabe R., Agbaje O.F., and Warwick J. Screening opportunity bias in case-control studies of cancer screening. J Appl Stat 51 (2002) 235-243
26. Coldman A., Phillips N., Warren L., and Kan L. Breast cancer mortality after screening mammography in British Columbia women. Int J Cancer 120 5 (2007) 1076-1080
27. Olsen A.H., Njor S.H., Vejborg I., Schwartz W., Dalgaard P., Jensen M.B., et al. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ 330 7485 (2005) 220
28. Anttila A., Koskela J., and Hakama M. Programme sensitivity and effectiveness of mammography service screening in Helsinki, Finland. J Med Screen 9 (2002) 153-158
29. Parvinen I., Helenius H., Pylkkanen L., Anttila A., Immonen-Raiha P., Kauhava L., et al. Service screening mammography reduces breast cancer mortality among elderly women in Turku. J Med Screen 13 1 (2006) 34-40
30. Sarkeala T., Heinävaara S., and Anttila A. Organised mammography screening reduces breast cancer mortality: a cohort study from Finland. Int J Cancer 122 (2008) 614-619
31. Sarkeala T., Heinävaara S., and Anttila A. Breast cancer mortality with varying invitational policies in organised mammography. Br J Cancer 98 (2008) 641-645
32. Gabe R., Tryggvadottir L., Sigfusson B.F., Olafsdottir G.H., Sigurdsson K., and Duffy S.W. A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death. Acta Radiol 48 9 (2007) 948-955
33. Paci E., Coviello E., Miccinesi G., et al. Evaluation of service mammography screening impact in Italy. The contribution of hazard analysis. Eur J Cancer 44 (2008) 858-865
34. Otto S.J., Fracheboud J., Looman C.W.N., Broeders M., Boer R., Hendriks J.H.C.L., et al. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet 361 (2003) 1411-1417
35. Erasmus MC USR. NETB interim report 2006. Main results breast cancer screening programme in the Netherlands. Rotterdam, The Netherlands; 2006.
36. Fracheboud J., Otto S.J., van Dijck J.A.A.M., Broeders M., Verbeek A.L.M., de Koning H.J., et al. Decreased rates of advanced breast cancer due to mammography screening in the Netherlands. Br J Cancer 91 (2004) 861-867
37. Ascunce E.N., Moreno-Iribas C., Barcos Urtiaga A., et al. Changes in breast cancer mortality in Navarre (Spain) after introduction of a screening programme. J Med Screen 14 (2007) 14-20
38. Swedish Organised Service Screening Evaluation Group. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data. Cancer Epidemiol Biomarkers Prev 15 1 (2006) 45-51
39. Swedish Organised Service Screening Evaluation Group. Reduction in breast cancer mortality from organized service screening with mammography: 2. Validation with alternative analytic methods. Cancer Epidemiol Biomarkers Prev 15 1 (2006) 52-56
40. Jonsson H., Nyström L., Törnberg S., and Lenner P. Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer. J Med Screen 8 (2001) 152-160
41. Tabar L., Vitak B., Tony H.H., Yen M.F., Duffy S.W., and Smith R.A. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer 91 (2001) 1724-1731
42. Jonsson H., Bordas P., Wallin H., Nyström L., and Lenner P. Service screening with mammography in Northern Sweden: effects on breast cancer mortality - an update. J Med Screen 14 (2007) 87-93
43. Cancer Research UK. UK breast cancer mortality statistics. ; 2009 [accessed 06.02.09; Ref. Type: Internet Communication].
44. McCann J., Duffy S., and Day N. Predicted long-term mortality reduction associated with the second round of breast screening in East Anglia. Br J Cancer 84 3 (2001) 423-428
45. Blanks R.G., Moss S.M., McGahan C.E., Quinn M.J., and Babb P.J. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality. BMJ 321 7262 (2000) 665-669
46. Allgood P.C., Warwick J., Warren R.M.L., Day N.E., and Duffy S.W. A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality. Br J Cancer 98 (2008) 206-209
47. Tabar L., Ming-Fang Y., Vitak B., Chen H.H., Smith R.A., and Duffy S.W. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet 361 (2003) 1405-1410
48. Vervoort M.M., Draisma G., Fracheboud J., van de Poll-Franse L.V., and de Koning H.J. Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality. Brit J Cancer 91 (2004) 242-247
49. Berry D.A., Cronin K.A., Plevritis S.K., Fryback D.G., Clarke L., Zelen M., et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353 17 (2005) 1784-1792